• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Osteoarthritis 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Osteoarthritis trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Osteoarthritis research

Clinical research is critical in the continued effort to identify symptom-relieving or disease-modifying treatments for osteoarthritis patients living with this debilitating condition. 

Signant Health can apply decades of direct clinical experience, deep therapeutic-area expertise, and innovative clinical trial technologies within our Signant SmartSignals platform to help researchers detect signal by increasing the quality and reliability of endpoint data.

Osteoarthritis-1

Why Signant Health

  • Mitigate Placebo Response
  • Gain Additional Patient Function Insights
  • Launch OA Studies Faster
  • Combine Solutions for an End-to-End Digitized Study
  • Increase Endpoint Data Accuracy
  • Mitigate Placebo Response

    Mitigate Placebo Response

    Site staff and investigators can unknowingly impact how patients respond to subjective patient-reported outcome assessments. Signant's expert clinical science and medicine team trains site staff to eliminate these interactions as factors in placebo response. This helps study teams better distinguish between placebo and active treatment response.
     

  • Gain Additional Patient Function Insights

    Gain Additional Patient Function Insights

    Sleep quality and activity measures provide relevant, objective insights into OA patient function and quality of life. Layer ActiGraph into your eCOA strategy to automatically collect sleep and activity data, with no additional burden on patients or sites.

    Data can be viewed together with COA data for a more complete assessment of patient function.

  • Launch OA Studies Faster

    Launch OA Studies Faster

    Accelerate the study startup process by obtaining informed consent, enrolling, and randomizing patients faster using Signant SmartSignals RTSM and eConsent Silver solutions. Both are designed for rapid deployment and simplified protocol amendment implementation.
     

  • Combine Solutions for an End-to-End Digitized Study

    Combine Solutions for an End-to-End Digitized Study

    Each solution and service within our Signant SmartSignals evidence generation platform can be used independently for site-based or remote studies, but when combined, they create a digital ecosystem for creating and managing accurate, regulatory-compliant clinical data.
     

  • Increase Endpoint Data Accuracy

    Increase Endpoint Data Accuracy

    Signant SmartSignals eCOA includes electronic versions of WOMAC, KOOS, and other common PROMs used in OA studies. ePROs have been proven to increase data accuracy compared to pencil and paper administration, and they also help OA patients complete assessments more comfortably. Sites have access to near real time data as well as assurances that PROs are completed correctly, completely, and on time.
     

Comprehensive Osteoarthritis experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Osteoarthritis trial resources
SOLUTION BROCHURE

Osteoarthritis Trial Solutions Overview


GET INSIGHTS
VIDEO

Osteoarthritis Trial Solutions



WATCH [2 MIN]
SOLUTION

Sensors and Wearables


 
LEARN MORE

eClinical Solutions for Osteoarthritis trials

Ready to learn more?

Discover how Signant can support your current or upcoming OA trials. 

DOWNLOAD BROCHURE GET STARTED